Welcome to Sequence Card of Peptide


Details of CPPsite entry with Sequence LSTAADMQGVVTDGMASGLDKDYLKPDD
Primary information
PEPTIDE SEQUENCELSTAADMQGVVTDGMASGLDKDYLKPDD
CPPsite ID 2102, 2103,
PEPTIDE NAMEp28, p28
CHIRALITYL, L
LINEAR/CYCLICLinear, Linear
SOURCEProtein derived, Protein derived
CATEGORYAnionic, Anionic
SUB CELLULAR LOCALIZATIONNA, NA
N-TERMINAL MODIFICATIONFree, Free
C-TERMINAL MODIFICATIONFree, Free
CHEMICAL MODIFICATIONNA, NA
UPTAKE EFFICIENCYNA, NA
PROPOSED UPTAKE MECHANISMNA, NA
INVITRO/INVIVOIn vitro and in vivo, In vitro
CELL LINEMCF-7, p53wt, isogenic MDD2, p53dom/neg, MDA-MB-231, p53mut, MCF- 10A, p53wt, UISO-Mel-6, p53null, UISO-Mel-23, p53mut, UISO-Mel-29, p53wt, MCF-7, MDA-MB-231, and T47D, HCT116 and HT29, HT1080, (HTB-88), osteosarcoma (TE85), rhabdomyosarcoma (RD), glioblastoma (U87 and LN229), neuroblastoma (SK-N-BE2), prostate cancer (DU145), pancreatic cancer (MIA-Paca2) and ovarian cancer (ES-2)]. Melanoma lines (UISO-Mel-23, 29
In VIVO MODELMale and female athymic mice, NA
CARGONA, NA
PMID23736031, 23952735
PATENTUnknown, Unknown
Tertiary Structure
(Technique)		2102 (PEPstrMOD), 2103 (PEPstrMOD),